e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
New insights into exercise and muscle performance
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inactivation of glycogen synthase kinase-3 is not required for recovery of muscle mass of disuse-atrophied muscle
Ramon Langen (Maastricht, Netherlands), Ramon Langen, Nicky Pansters, Marco Kelders, Chiel De Theije, Annemie Schols
Source:
International Congress 2015 – New insights into exercise and muscle performance
Session:
New insights into exercise and muscle performance
Session type:
Poster Discussion
Number:
4606
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ramon Langen (Maastricht, Netherlands), Ramon Langen, Nicky Pansters, Marco Kelders, Chiel De Theije, Annemie Schols. Inactivation of glycogen synthase kinase-3 is not required for recovery of muscle mass of disuse-atrophied muscle. Eur Respir J 2015; 46: Suppl. 59, 4606
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances skeletal muscle oxidative metabolism
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Skeletal muscle atrophy caused by acute pulmonary inflammation is dependent on a glycogen synthase kinase-3beta - glucocorticoid receptor signaling axis
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
Hypoxia sensitizes skeletal muscle to fasting-induced muscle atrophy; role of AMPK activation
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Muscle morphology, metabolism and muscle function: general principles
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=86
Year: 2003
TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
GSK-3β is required for the induction of skeletal muscle atrophy
Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function
Year: 2010
Parallel activation of autophagy and myogenesis during muscle mass recovery following disuse-atrophy
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Pectoralis muscle area and skeletal muscle strength in patients with ILD
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016
Features of skeletal muscle dysfunction in COPD patients with obesity
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Hypoxia signaling and muscle mass regulation in skeletal muscle of mice exposed to hypoxia
Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Year: 2010
Effects of inflammation on skeletal muscle
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=68
Year: 2003
Altered muscle metabolism and muscle mass in patients with COPD
Source: International Congress 2017 – Neuromuscular consequences of respiratory diseases
Year: 2017
Skeletal muscle strength in critical illness
Source: Eur Respir J 2005; 26: Suppl. 49, 242s
Year: 2005
Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
Effects of electrical muscle stimulation early in the quadriceps and tibialis anterior muscle of critically ill patients
Source: Annual Congress 2013 –Exercise and physiotherapy in non-COPD conditions and in the assessment of healthy subjects
Year: 2013
Skeletal muscle oxidative capacity is an independent predictor of physical activity in smokers with and without COPD
Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease
Year: 2015
Assessment of muscle function
Source: School Course 2012 - Practical Issues in Pulmonary Rehabilitation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept